Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Safety and tolerability of methylphenidate in preschool children with ADHD.

Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCracken J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A.

J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1294-303.

PMID:
17028508
[PubMed - indexed for MEDLINE]
2.

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.

Greenhill L, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK, Gillberg C, Huss M, Jensen P, Kennedy JL, Klein R, Rapoport J, Sagvolden T, Spencer T, Swanson JM, Volkow N.

J Atten Disord. 2002;6 Suppl 1:S89-100. Review.

PMID:
12685523
[PubMed - indexed for MEDLINE]
3.

[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

Golubchik P, Sever J, Weizman A.

Harefuah. 2011 Oct;150(10):788-90, 814. Review. Hebrew.

PMID:
22111124
[PubMed - indexed for MEDLINE]
4.

Pharmacological treatment of ADHD and the short and long term effects on sleep.

Huang YS, Tsai MH, Guilleminault C.

Curr Pharm Des. 2011;17(15):1450-8. Review.

PMID:
21476954
[PubMed - indexed for MEDLINE]
5.

Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.

Rapoport JL, Inoff-Germain G.

J Atten Disord. 2002;6 Suppl 1:S57-60. Review.

PMID:
12685519
[PubMed - indexed for MEDLINE]
6.

Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.

Anderson VR, Scott LJ.

Drugs. 2006;66(8):1117-26. Review.

PMID:
16789796
[PubMed - indexed for MEDLINE]
7.

[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].

Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.

Psychiatr Pol. 2009 Mar-Apr;43(2):183-92. Review. Polish.

PMID:
19697788
[PubMed - indexed for MEDLINE]
8.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920
[PubMed - indexed for MEDLINE]
9.

Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.

Tan M, Appleton R.

Arch Dis Child. 2005 Jan;90(1):57-9. Review.

PMID:
15613514
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.

Kociancic T, Reed MD, Findling RL.

Expert Opin Drug Saf. 2004 Mar;3(2):93-100. Review.

PMID:
15006715
[PubMed - indexed for MEDLINE]
11.

Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.

Lurie S, O'Quinn A.

J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):41-50. Review.

PMID:
7580171
[PubMed - indexed for MEDLINE]
12.

Disordered sleep in pediatric patients with attention deficit hyperactivity disorder: an overview.

Ganelin-Cohen E, Ashkenasi A.

Isr Med Assoc J. 2013 Nov;15(11):705-9. Review.

PMID:
24511653
[PubMed - indexed for MEDLINE]
Free Article
13.

[Methylphenidate misuse].

Bruggisser M, Bodmer M, Liechti ME.

Praxis (Bern 1994). 2012 Feb 29;101(5):299-305. doi: 10.1024/1661-8157/a000856. Review. German.

PMID:
22377977
[PubMed - indexed for MEDLINE]
14.

Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason.

Batra AS, Alexander ME, Silka MJ.

Pediatr Cardiol. 2012 Mar;33(3):394-401. doi: 10.1007/s00246-012-0162-6. Review.

PMID:
22298228
[PubMed - indexed for MEDLINE]
15.

Exposure to attention deficit hyperactivity disorder medications during pregnancy.

Humphreys C, Garcia-Bournissen F, Ito S, Koren G.

Can Fam Physician. 2007 Jul;53(7):1153-5. Review.

PMID:
17872810
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Safety issues in the use of methylphenidate. An American perspective.

Rappley MD.

Drug Saf. 1997 Sep;17(3):143-8. Review.

PMID:
9306050
[PubMed - indexed for MEDLINE]
17.

[The practice and problem of therapeutic agents for AD/HD].

Tanaka H, Miyajima T.

No To Hattatsu. 2010 May;42(3):213-6. Review. Japanese. No abstract available.

PMID:
23858580
[PubMed - indexed for MEDLINE]
18.

FPIN's clinical inquiries: Management of ADHD in preschool-aged children.

Klein S, Ho V, Tazkarji B, Auten B.

Am Fam Physician. 2013 Sep 15;88(6):398-400. Review. No abstract available.

PMID:
24134048
[PubMed - indexed for MEDLINE]
Free Article
19.

Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?

Gerlach M, Gr├╝nblatt E, Lange KW.

Atten Defic Hyperact Disord. 2013 Jun;5(2):71-81. doi: 10.1007/s12402-013-0105-y. Epub 2013 Apr 21. Review.

PMID:
23605387
[PubMed - indexed for MEDLINE]
20.

ADHD interventions in children younger than six years.

Salisbury-Afshar E.

Am Fam Physician. 2013 Aug 15;88(4):266-8. Review. No abstract available.

PMID:
23944731
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk